CEA – Carcino Embryonic Antigen

The CEA (Carcinoembryonic Antigen) test is a blood test used primarily to monitor certain types of cancers, especially colorectal, pancreatic, gastric, breast, and lung cancers. CEA is a protein normally present at low levels in adults but can rise when certain cancers are present. This test is not typically used for initial cancer diagnosis but is valuable in tracking treatment response, detecting recurrence, and monitoring disease progression. Elevated CEA levels can also occur in non-cancerous conditions such as smoking, inflammation, liver disease, or infections. Doctors interpret results alongside clinical findings and imaging studies to guide management and follow-up care.Reports On : With 12 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

0 Comments

CD4 CD8

The CD4/CD8 test measures the levels of two types of T-lymphocytes—CD4+ helper T cells and CD8+ cytotoxic T cells—in the blood. CD4 cells play a crucial role in coordinating the immune response by signaling other cells, while CD8 cells are responsible for directly attacking infected or abnormal cells. This test is commonly used to assess immune function, especially in individuals with HIV/AIDS, autoimmune disorders, or those undergoing immunosuppressive therapy. The CD4/CD8 ratio provides insight into immune balance, helping monitor disease progression, treatment effectiveness, and overall immune health.Reports On : With 24 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

0 Comments

CCP Antibody Cyclic Citrullinated Peptide

The CCP Antibody test, also known as the Anti-Cyclic Citrullinated Peptide test, is a blood test used to detect antibodies directed against cyclic citrullinated peptides. These antibodies are highly specific markers for rheumatoid arthritis (RA) and may appear in the blood years before clinical symptoms develop. Detecting CCP antibodies helps in early diagnosis, monitoring disease progression, and guiding treatment decisions. A positive result, especially when combined with elevated rheumatoid factor, strongly indicates RA. Early detection through CCP testing allows for timely intervention, reducing joint damage and improving long-term outcomes.Reports On : With 12 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

0 Comments